Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$136.55M
Total Bought:
$19.44M
Total Sold:
$28.86M
Net Transaction:
-$9.42M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
270,000270,0000$27.19M$27.19M19.91%$0
Atea Pharmaceuticals, Inc.(AVIR)5,536,7106,375,621+838,911$22.37M$21.10M15.45%-$1.27M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
200,000200,0000$18.36M$18.36M13.44%-$4.0K
Aclaris Therapeutics, Inc.(ACRS)9,395,93412,988,134+3,592,200$11.65M$14.29M10.46%+$2.64M
Adverum Biotechnologies Inc833,1171,966,000+1,132,883$11.78M$13.49M9.88%+$1.71M
Tectonic Therapeutic, Inc.(TECX)0466,047+466,047$0$7.68M5.62%+$7.68M
Reneo Pharmaceuticals Inc2,177,9132,672,194+494,281$3.62M$4.04M2.95%+$419.7K
Instil Bio, Inc.(TIL)348,735391,103+42,368$3.77M$4.02M2.95%+$258.1K
Oramed Pharmaceuticals Inc.(ORMP)844,4961,349,038+504,542$2.47M$3.47M2.54%+$1.00M
Connect Biopharma Hldgs LtdADS2,061,3382,043,248-18,090$3.59M$3.11M2.27%-$481.0K
Athira Pharma Inc900,000900,0000$2.47M$2.38M1.75%-$81.0K
Vanda Pharmaceuticals Inc.(VNDA)0398,280+398,280$0$2.25M1.65%+$2.25M
PMV Pharmaceuticals, Inc.(PMVP)1,306,4901,309,397+2,907$2.22M$2.12M1.55%-$99.8K
Astrotech Corp220,410220,4100$1.97M$1.96M1.44%-$11.0K
Milestone Pharmaceuticals Inc.(MIST)606,1451,102,895+496,750$1.08M$1.46M1.07%+$370.8K
Design Therapeutics, Inc.(DSGN)879,478421,749-457,729$3.54M$1.41M1.03%-$2.13M
Verrica Pharmaceuticals Inc.(VRCA)180,000180,0000$1.07M$1.31M0.96%+$246.6K
LENZ Therapeutics, Inc.(LENZ)63,91663,9160$1.43M$1.11M0.81%-$322.1K
Lisata Therapeutics, Inc.(LSTA)284,669284,6690$888.2K$987.8K0.72%+$99.6K
Ikena Oncology Inc0585,114+585,114$0$965.4K0.71%+$965.4K
Forte Biosciences Inc1,761,7021,761,7020$1.23M$946.0K0.69%-$280.5K
CalciMedica, Inc.(CALC)160,424160,4240$667.4K$635.3K0.47%-$32.1K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$792.0K$522.0K0.38%-$270.0K
Achilles Therapeutics PlcADS0625,174+625,174$0$509.5K0.37%+$509.5K
Nextcure Inc306,465276,465-30,000$683.4K$439.6K0.32%-$243.8K
Allovir Inc200,464603,086+402,622$151.3K$436.2K0.32%+$284.9K
Talis Biomedical Corp42,74342,7430$374.0K$370.2K0.27%-$3.8K
Arca Biopharma Inc706,9300-706,930$1.24M$0—-$1.24M
Avrobio Inc4,001,6270-4,001,627$5.12M$0—-$5.12M
Cyteir Therapeutics Inc3,654,0530-3,654,053$11.00M$0—-$11.00M
Climb Bio, Inc.(CLYM)2,193,7420-2,193,742$6.01M$0—-$6.01M
Enliven Therapeutics Inc50,1000-50,100$881.3K$0—-$881.3K
Kinnate Biopharma Inc498,8510-498,851$1.33M$0—-$1.33M
Q32 Bio Inc.(QTTB)24,8940-24,894$424.2K$0—-$424.2K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q2 2024 | TickerTrail